| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| Other Sizes |
| Targets |
Nav1.4 muscle sodium channel. Methocarbamol blocks Nav1.4 channels, reducing muscle excitability and spasm.
|
|---|---|
| ln Vitro |
Methocarbamol D5 is a deuterium-labeled analog. The parent compound methocarbamol is an orally active central muscle relaxant that blocks Nav1.4 muscle channels. It shows sedative properties and is used clinically for musculoskeletal pain.
|
| ln Vivo |
Methocarbamol D5 is primarily used as an analytical reference standard. The parent compound methocarbamol has been evaluated in clinical trials for musculoskeletal pain. It is well absorbed orally and metabolized in the liver.
|
| Enzyme Assay |
Nav1.4 channel binding assays use recombinant Nav1.4 channels expressed in cell membranes. Radiolabeled batrachotoxin (3H-batrachotoxin) or other sodium channel ligands are incubated with membrane preparations and serially diluted test compound. Bound radioactivity is quantified, and Ki values are calculated.
|
| Cell Assay |
Cell-based assays for Nav1.4 channel activity use HEK293 or CHO cells expressing recombinant Nav1.4 channels. Sodium currents are measured by patch-clamp electrophysiology in the presence or absence of test compound. IC50 values are determined from dose-response curves.
|
| Animal Protocol |
In vivo studies with Methocarbamol D5 focus on pharmacokinetic characterization. Rats or mice are administered the compound, and plasma concentrations are measured by LC-MS/MS. Parameters such as Cmax, Tmax, AUC, t1/2, and clearance are determined. The deuterium isotope effect on metabolic stability is evaluated.
|
| References |
| Molecular Formula |
C11H10D5NO5
|
|---|---|
| Molecular Weight |
246.2713
|
| Exact Mass |
246.126
|
| CAS # |
1189699-70-4
|
| Related CAS # |
Methocarbamol;532-03-6
|
| PubChem CID |
46782130
|
| Appearance |
Typically exists as solid at room temperature
|
| LogP |
1.044
|
| tPSA |
92
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
5
|
| Rotatable Bond Count |
7
|
| Heavy Atom Count |
17
|
| Complexity |
236
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
COC1=CC=CC=C1OC(C(C(OC(=O)N)([2H])[2H])([2H])O)([2H])[2H]
|
| InChi Key |
GNXFOGHNGIVQEH-RORPNYJOSA-N
|
| InChi Code |
InChI=1S/C11H15NO5/c1-15-9-4-2-3-5-10(9)16-6-8(13)7-17-11(12)14/h2-5,8,13H,6-7H2,1H3,(H2,12,14)/i6D2,7D2,8D
|
| Chemical Name |
[1,1,2,3,3-pentadeuterio-2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.0606 mL | 20.3029 mL | 40.6058 mL | |
| 5 mM | 0.8121 mL | 4.0606 mL | 8.1212 mL | |
| 10 mM | 0.4061 mL | 2.0303 mL | 4.0606 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.